UNI-MB - logo
UMNIK - logo
 
E-viri
Recenzirano Odprti dostop
  • Percutaneous Mechanical Cir...
    Ouweneel, Dagmar M.; Eriksen, Erlend; Seyfarth, Melchior; Henriques, José P.S.

    Journal of the American College of Cardiology, 01/2017, Letnik: 69, Številka: 3
    Journal Article

    All trials were underpowered to adequately evaluate mortality. ...we pooled the data from these trials to compare Impella with IABP on 30-day and 6-month all-cause mortality and left ventricular ejection fraction (LVEF) during follow-up. ...although there is only limited data available, this meta-analysis shows no difference in mortality or LVEF in cardiogenic shock patients who are treated with Impella compared with IABP.